GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Smith & Nephew PLC (NYSE:SNN) » Definitions » Debt-to-Asset

SNN (Smith & Nephew) Debt-to-Asset : 0.35 (As of Jun. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Smith & Nephew Debt-to-Asset?

Smith & Nephew's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was $380 Mil. Smith & Nephew's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was $3,275 Mil. Smith & Nephew's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2024 was $10,542 Mil. Smith & Nephew's debt to asset for the quarter that ended in Jun. 2024 was 0.35.


Smith & Nephew Debt-to-Asset Historical Data

The historical data trend for Smith & Nephew's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Smith & Nephew Debt-to-Asset Chart

Smith & Nephew Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.22 0.34 0.31 0.29 0.31

Smith & Nephew Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.29 0.29 0.31 0.31 0.35

Competitive Comparison of Smith & Nephew's Debt-to-Asset

For the Medical Devices subindustry, Smith & Nephew's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Smith & Nephew's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Smith & Nephew's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Smith & Nephew's Debt-to-Asset falls into.



Smith & Nephew Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Smith & Nephew's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Smith & Nephew's Debt-to-Asset for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Smith & Nephew  (NYSE:SNN) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Smith & Nephew Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Smith & Nephew's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Smith & Nephew Business Description

Address
Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, GBR, WD18 8YE
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Smith & Nephew Headlines